Effects of Oral Pre-loads on Subsequent Energy Intake
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this project is to investigate the effect of erythritol (given as pre-load), compared to sucrose, sucralose, and water on energy intake during a subsequent ad libitum test meal in healthy participants. Furthermore, the release of GI hormones, glycemic control, appetite-related sensations, GI tolerance, sweetness and liking in response to the pre-loads will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 19, 2021
CompletedStudy Start
First participant enrolled
February 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2021
CompletedDecember 16, 2021
December 1, 2021
4 months
January 13, 2021
December 15, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Effect of erythritol on energy intake during a subsequent ad libitum test meal
Fifteen minutes after the administration of the pre-loads (t = 0 minutes), a standard solid test meal will be presented and ad libitum calorie intake will be measured.
Total energy intake will be measured from t = 0 until t = 20 minutes or as soon as the as the subject stops eating for more than 5 minutes.
Secondary Outcomes (13)
Effects on GI hormone response - GLP-1
Blood will be drawn at the following time points: t = -16, t = -1 (before the administration of the pre-load), t = 15, t = 30, t = 60, t = 90, t = 120, t = 150, t = 180 minutes (after the administration of the pre-load).
Effects on GI hormone response - PYY
Blood will be drawn at the following time points :t = -16, t = -1 (before the administration of the pre-load), t = 15, t = 30, t = 60, t = 90, t = 120, t = 150, t = 180 minutes (after the administration of the pre-load).
Effects on GI hormone response - CCK
Blood will be drawn at the following time points: t = -16, t = -1 (before the administration of the pre-load), t = 15, t = 30, t = 60, t = 90, t = 120, t = 150, t = 180 minutes (after the administration of the pre-load).
Effects on GI hormone response - ghrelin
Blood will be drawn at the following time points: t = -16, t = -1 (before the administration of the pre-load), t = 15, t = 30, t = 60, t = 90, t = 120, t = 150, t = 180 minutes (after the administration of the pre-load).
Effects on glycemic control - plasma glucose
Blood will be drawn at the following time points: t = -16, t = -1 (before administration of the pre-load), t = 15, t = 30, t = 60, t = 90, t = 120, t = 150, t = 180 minutes (after the administration of the pre-load).
- +8 more secondary outcomes
Study Arms (4)
Erythritol
ACTIVE COMPARATOR20 volunteers receive 50g erythritol dissolved in 300mL tap water as an oral pre-load.
Sucrose
ACTIVE COMPARATOR20 volunteers receive 33.5g sucrose dissolved in 300mL tap water as an oral pre-load.
Sucralose
ACTIVE COMPARATOR20 volunteers receive 0.0558g sucralose dissolved in 300mL tap water as an oral pre-load.
Water
PLACEBO COMPARATOR20 volunteers receive 300mL tap water as an oral pre-load.
Interventions
50g erythritol dissolved in 300mL tap water.
33.5g sucrose dissolved in 300mL tap water.
0.0558g sucralose dissolved in 300mL tap water.
Eligibility Criteria
You may qualify if:
- Healthy normal weight subjects with a body-mass index of 19.0-24.9
- Normal eating habits (eating breakfast; no diets; no dietary changes; no vegetarians/vegans, no intolerances/allergies)
- Age 18-55 years
- Stable body weight (+/- 5%) for at least three months
- Informed Consent as documented by signature (Appendix Informed Consent Form)
You may not qualify if:
- Shift worker
- Fructose intolerance
- Pre-existing consumption of erythritol and/or sucralose more than once a week
- Substance abuse
- Regular intake of medications, except anticontraceptive
- Chronic or clinically relevant acute infections
- Pregnancy: although no contraindication, pregnancy might influence metabolic state. Women who are pregnant or have the intention to become pregnant during the course of the study are excluded. Female participants of childbearing age have to use safe contraception (oral, injectable, or implantable contraceptives, intrauterine contraceptive devices, or tubectomy). In female participants a urine pregnancy test is carried out upon screening.
- Participation in another study with investigational drug within the 30 days preceding and during the present study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Claraspital
Basel, 4002, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Christin Meyer-Gerspach, PD, PhD
St. Clara Research Ltd.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2021
First Posted
January 19, 2021
Study Start
February 5, 2021
Primary Completion
June 3, 2021
Study Completion
June 3, 2021
Last Updated
December 16, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share